Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In 2025, something unexpected happened. The programming language most notorious for its difficulty became the go-to choice ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results